Compare TUSK & ADVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TUSK | ADVB |
|---|---|---|
| Founded | 2014 | 2014 |
| Country | United States | United States |
| Employees | N/A | 31 |
| Industry | Oilfield Services/Equipment | Medical Specialities |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 102.2M | 109.2M |
| IPO Year | 2016 | N/A |
| Metric | TUSK | ADVB |
|---|---|---|
| Price | $2.46 | $4.40 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 330.6K | 90.5K |
| Earning Date | 03-06-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 102.32 | N/A |
| EPS | ★ 0.10 | N/A |
| Revenue | ★ $44,292,000.00 | N/A |
| Revenue This Year | $383.90 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $26.20 | ★ $1.26 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.68 | $0.19 |
| 52 Week High | $2.96 | $5.82 |
| Indicator | TUSK | ADVB |
|---|---|---|
| Relative Strength Index (RSI) | 54.76 | 57.33 |
| Support Level | $2.13 | $0.36 |
| Resistance Level | $2.50 | $5.71 |
| Average True Range (ATR) | 0.15 | 0.28 |
| MACD | 0.05 | -0.18 |
| Stochastic Oscillator | 48.58 | 31.94 |
Mammoth Energy Services Inc is an integrated energy services company engaged in providing products and services to enable the exploration and development of North American onshore unconventional oil and natural gas reserves as well as the construction and repair of the electric grid for private utilities, public investor-owned utilities, and co-operative utilities through infrastructure services businesses. The company had three reportable segments, which includes well completion services (Well Completion), infrastructure services (Infrastructure) and natural sand proppant services (Sand). Key revenue is generated from Infrastructure which include electric utility infrastructure services to government-funded utilities, private utilities, public investor-owned utilities, etc.
Advanced Biomed Inc operates through its subsidiaries and is mainly engaged in the research and development of various original microfluidic biochip technologies and the provision of tumor precision diagnosis and treatment technology applications. Through the joint application of semiconductor technology and biotechnology, it has developed various technologies and testing equipment for early screening and detection, diagnosis and staging, and treatment of cancer. Its devices: A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip, and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.